Retention Rate and Safety of Biologic and Targeted Synthetic DMARDs in Patients with RA-Associated Interstitial Lung Disease: A KOBIO Registry Study.
Sun-Kyung LeeKichul ShinJu-Yang JungChang-Hee SuhJi-Won KimWook-Young BaekPublished in: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy (2023)
The patients with RA-ILD had lower bDMARD and tsDMARD retention rates than those with RA-no ILD. In the RA-ILD group, current smoking and concomitant corticosteroid use were associated factors affecting drug withdrawal.